DOCSLIB.ORG

Mouse Stk39 Conditional Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Stk39 Conditional Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Stk39 Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Stk39 conditional knockout Mouse model (C57BL/6N) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Stk39 gene (NCBI Reference Sequence: NM_016866 ; Ensembl: ENSMUSG00000027030 ) is located on Mouse chromosome 2. 18 exons are identified, with the ATG start codon in exon 1 and the TGA stop codon in exon 18 (Transcript: ENSMUST00000102715). Exon 2 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Stk39 gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP24-153H9 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mice homozygous for a null allele exhibit reduced bumetanide-sensitive thallium, a potassium tracer, uptake in dorsal root ganglion neurons and reduced fertility. Mice with an ENU mutation in intron 8 exhibit elevated albumin- creatinine (ACR) ratios. Exon 2 starts from about 14.69% of the coding region. The knockout of Exon 2 will result in frameshift of the gene. The size of intron 1 for 5'-loxP site insertion: 61492 bp, and the size of intron 2 for 3'-loxP site insertion: 11496 bp. The size of effective cKO region: ~613 bp. The cKO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele gRNA region 5' gRNA region 3' 1 2 18 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Stk39 Homology arm cKO region loxP site Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats. Tandem repeats are found in the dot plot matrix. It may be difficult to construct this targeting vector. Overview of the GC Content Distribution Window size: 300 bp Sequence 12 Summary: Full Length(7113bp) | A(24.45% 1739) | C(21.69% 1543) | T(31.38% 2232) | G(22.48% 1599) Note: The sequence of homologous arms and cKO region is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 8 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr2 - 68410392 68413391 3000 browser details YourSeq 76 1201 1283 3000 93.8% chr7 + 64988801 64988881 81 browser details YourSeq 74 1206 1279 3000 100.0% chr14 - 10634115 10634188 74 browser details YourSeq 74 1198 1271 3000 100.0% chr18 + 40689269 40689342 74 browser details YourSeq 61 1224 1287 3000 98.5% chr2 + 58591923 58591992 70 browser details YourSeq 51 1203 1253 3000 100.0% chr14 - 95916193 95916243 51 browser details YourSeq 50 1151 1200 3000 100.0% chr8 + 58177099 58177148 50 browser details YourSeq 46 1229 1274 3000 100.0% chr13 - 17959588 17959633 46 browser details YourSeq 45 1152 1198 3000 93.5% chr6 - 94978171 94978216 46 browser details YourSeq 41 1160 1203 3000 90.5% chr16 + 72975145 72975186 42 browser details YourSeq 40 1154 1197 3000 95.5% chr19 + 47522910 47522953 44 browser details YourSeq 34 1766 1861 3000 91.9% chr13 - 49895386 49895480 95 browser details YourSeq 32 1768 1861 3000 91.5% chr13 + 50847494 50847586 93 browser details YourSeq 32 959 1087 3000 97.1% chr12 + 106557731 106558038 308 browser details YourSeq 31 1061 1201 3000 97.0% chr9 - 39007506 39007646 141 browser details YourSeq 31 1171 1203 3000 97.0% chr2 + 45895234 45895266 33 browser details YourSeq 28 1152 1183 3000 93.8% chr6 + 91870700 91870731 32 browser details YourSeq 26 937 965 3000 96.5% chr10 - 9686245 9686276 32 browser details YourSeq 23 2845 2871 3000 88.0% chr12 - 70473746 70473771 26 browser details YourSeq 21 2387 2407 3000 100.0% chr16 - 71959241 71959261 21 Note: The 3000 bp section upstream of Exon 2 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr2 - 68406779 68409778 3000 browser details YourSeq 43 2525 2574 3000 93.9% chr10 - 21325057 21325106 50 browser details YourSeq 24 166 189 3000 100.0% chr11 - 77727640 77727663 24 browser details YourSeq 23 1003 1026 3000 100.0% chr17 - 72000706 72000730 25 browser details YourSeq 22 1056 1080 3000 95.9% chr8 - 79679671 79679696 26 browser details YourSeq 22 390 413 3000 87.0% chr5 - 17571069 17571091 23 browser details YourSeq 22 1783 1804 3000 100.0% chr3 - 70634881 70634902 22 browser details YourSeq 22 457 478 3000 100.0% chr11 - 35105505 35105526 22 browser details YourSeq 21 889 909 3000 100.0% chr6 - 59362931 59362951 21 Note: The 3000 bp section downstream of Exon 2 is BLAT searched against the genome. No significant similarity is found. Page 4 of 8 https://www.alphaknockout.com Gene and protein information: Stk39 serine/threonine kinase 39 [ Mus musculus (house mouse) ] Gene ID: 53416, updated on 10-Oct-2019 Gene summary Official Symbol Stk39 provided by MGI Official Full Name serine/threonine kinase 39 provided by MGI Primary source MGI:MGI:1858416 See related Ensembl:ENSMUSG00000027030 Gene type protein coding RefSeq status PROVISIONAL Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as DCHT; Rnl5; SPAK; RF005; AW227544; AW556857 Expression Broad expression in testis adult (RPKM 29.2), cerebellum adult (RPKM 12.7) and 19 other tissues See more Orthologs human all Genomic context Location: 2; 2 C1.3 See Stk39 in Genome Data Viewer Exon count: 22 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 2 NC_000068.7 (68210445..68472108, complement) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 2 NC_000068.6 (68048504..68310038, complement) Chromosome 2 - NC_000068.7 Page 5 of 8 https://www.alphaknockout.com Transcript information: This gene has 8 transcripts Gene: Stk39 ENSMUSG00000027030 Description serine/threonine kinase 39 [Source:MGI Symbol;Acc:MGI:1858416] Gene Synonyms DCHT, RF005, Rnl5, SPAK Location Chromosome 2: 68,210,445-68,472,268 reverse strand. GRCm38:CM000995.2 About this gene This gene has 8 transcripts (splice variants), 205 orthologues, 35 paralogues, is a member of 1 Ensembl protein family and is associated with 25 phenotypes. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Stk39-201 ENSMUST00000102715.3 3536 556aa ENSMUSP00000099776.3 Protein coding CCDS16084 A2AQL0 Q9Z1W9 TSL:1 GENCODE basic APPRIS P1 Stk39-203 ENSMUST00000126663.7 2578 No protein - Retained intron - - TSL:1 Stk39-202 ENSMUST00000123781.7 2038 No protein - Retained intron - - TSL:1 Stk39-208 ENSMUST00000149581.1 737 No protein - lncRNA - - TSL:5 Stk39-205 ENSMUST00000134442.7 492 No protein - lncRNA - - TSL:3 Stk39-206 ENSMUST00000139407.1 473 No protein - lncRNA - - TSL:3 Stk39-204 ENSMUST00000130380.7 452 No protein - lncRNA - - TSL:3 Stk39-207 ENSMUST00000144457.1 414 No protein - lncRNA - - TSL:3 Page 6 of 8 https://www.alphaknockout.com 281.82 kb Forward strand 68.25Mb 68.30Mb 68.35Mb 68.40Mb 68.45Mb Genes Gm13596-201 >lncRNA (Comprehensive set... Contigs BX936296.17 > AL845486.6 > AL844841.10 > Genes (Comprehensive set... < Stk39-201protein coding < Stk39-203retained intron < Stk39-207lncRNA < Stk39-202retained intron < Stk39-205lncRNA < Stk39-208lncRNA < Stk39-204lncRNA < Stk39-206lncRNA Regulatory Build 68.25Mb 68.30Mb 68.35Mb 68.40Mb 68.45Mb Reverse strand 281.82 kb Regulation Legend CTCF Enhancer Open Chromatin Promoter Promoter Flank Transcription Factor Binding Site Gene Legend Protein Coding merged Ensembl/Havana Non-Protein Coding RNA gene processed transcript Page 7 of 8 https://www.alphaknockout.com Transcript: ENSMUST00000102715 < Stk39-201protein coding Reverse strand 261.82 kb ENSMUSP00000099... PDB-ENSP mappings MobiDB lite Low complexity (Seg) Superfamily Protein kinase-like domain superfamily SMART Protein kinase domain Pfam Protein kinase domain Serine/threonine-protein kinase OSR1/WNK, CCT domain PROSITE profiles Protein kinase domain PROSITE patterns Protein kinase, ATP binding site PANTHER PTHR24361 PTHR24361:SF671 Gene3D 3.30.200.20 1.10.510.10 3.10.20.90 CDD cd06610 All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend missense variant synonymous variant Scale bar 0 60 120 180 240 300 360 420 480 556 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 8 of 8.
Load more

Recommended publications
  • Role and Regulation of the P53-Homolog P73 in the Transformation of Normal Human Fibroblasts
    Role and regulation of the p53-homolog p73 in the transformation of normal human fibroblasts Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der Bayerischen Julius-Maximilians-Universität Würzburg vorgelegt von Lars Hofmann aus Aschaffenburg Würzburg 2007 Eingereicht am Mitglieder der Promotionskommission: Vorsitzender: Prof. Dr. Dr. Martin J. Müller Gutachter: Prof. Dr. Michael P. Schön Gutachter : Prof. Dr. Georg Krohne Tag des Promotionskolloquiums: Doktorurkunde ausgehändigt am Erklärung Hiermit erkläre ich, dass ich die vorliegende Arbeit selbständig angefertigt und keine anderen als die angegebenen Hilfsmittel und Quellen verwendet habe. Diese Arbeit wurde weder in gleicher noch in ähnlicher Form in einem anderen Prüfungsverfahren vorgelegt. Ich habe früher, außer den mit dem Zulassungsgesuch urkundlichen Graden, keine weiteren akademischen Grade erworben und zu erwerben gesucht. Würzburg, Lars Hofmann Content SUMMARY ................................................................................................................ IV ZUSAMMENFASSUNG ............................................................................................. V 1. INTRODUCTION ................................................................................................. 1 1.1. Molecular basics of cancer .......................................................................................... 1 1.2. Early research on tumorigenesis ................................................................................. 3 1.3. Developing
    [Show full text]
  • Genomic Selection Signatures in Autism Spectrum Disorder Identifies
    www.nature.com/scientificreports OPEN Genomic selection signatures in autism spectrum disorder identifes cognitive genomic tradeof and its relevance in paradoxical phenotypes of defcits versus potentialities Anil Prakash1,2 & Moinak Banerjee1* Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental disorder characterized by paradoxical phenotypes of defcits as well as gain in brain function. To address this a genomic tradeof hypothesis was tested and followed up with the biological interaction and evolutionary signifcance of positively selected ASD risk genes. SFARI database was used to retrieve the ASD risk genes while for population datasets 1000 genome data was used. Common risk SNPs were subjected to machine learning as well as independent tests for selection, followed by Bayesian analysis to identify the cumulative efect of selection on risk SNPs. Functional implication of these positively selected risk SNPs was assessed and subjected to ontology analysis, pertaining to their interaction and enrichment of biological and cellular functions. This was followed by comparative analysis with the ancient genomes to identify their evolutionary patterns. Our results identifed signifcant positive selection signals in 18 ASD risk SNPs. Functional and ontology analysis indicate the role of biological and cellular processes associated with various brain functions. The core of the biological interaction network constitutes genes for cognition and learning while genes in the periphery of the network had direct or indirect impact on brain function. Ancient genome analysis identifed de novo and conserved evolutionary selection clusters. The de-novo evolutionary cluster represented genes involved in cognitive function. Relative enrichment of the ASD risk SNPs from the respective evolutionary cluster or biological interaction networks may help in addressing the phenotypic diversity in ASD.
    [Show full text]
  • Comparative Transcriptome Profiling of Selected Osmotic Regulatory Proteins in the Gill During Seawater Acclimation of Chum Salm
    www.nature.com/scientificreports OPEN Comparative transcriptome profling of selected osmotic regulatory proteins in the gill during seawater acclimation of chum salmon (Oncorhynchus keta) fry Sang Yoon Lee 1, Hwa Jin Lee2 & Yi Kyung Kim1,2* Salmonid fshes, chum salmon (Oncorhynchus keta) have the developed adaptive strategy to withstand wide salinity changes from the early life stage. This study investigated gene expression patterns of cell membrane proteins in the gill of chum salmon fry on the transcriptome level by tracking the salinity acclimation of the fsh in changing environments ranging from freshwater (0 ppt) to brackish water (17.5 ppt) to seawater (35 ppt). Using GO analysis of DEGs, the known osmoregulatory genes and their functional groups such as ion transport, transmembrane transporter activity and metal ion binding were identifed. The expression patterns of membrane protein genes, including pump-mediated protein (NKA, CFTR), carrier-mediated protein (NKCC, NHE3) and channel-mediated protein (AQP) were similar to those of other salmonid fshes in the smolt or adult stages. Based on the protein-protein interaction analysis between transmembrane proteins and other related genes, we identifed osmotic-related genes expressed with salinity changes and analyzed their expression patterns. The fndings of this study may facilitate the disentangling of the genetic basis of chum salmon and better able an understanding of the osmophysiology of the species. Salinity is one of the critical factors limiting the distribution patterns of all aquatic organisms1–4. Salmonid fshes display diverse life-history traits; anadromous individuals that mature in the river from hatching through to juveniles acquire the capacity to tolerate salinity associated with parr–smolt transformation and undergo ocean migrations before returning to rivers for spawning, whereas landlocked types spend their entire life within fresh- water5,6.
    [Show full text]
  • Nngv3n5-Issue-Text-Proof.Pdf
    An Official Journal of the American Academy of Neurology Neurology.org/ng • Online ISSN: 2376-7839 Volume 3, Number 5, October 2017 Genetics Moderate blast exposure Design and rationale for Genome-wide scan alters gene expression examining neuroimaging in Hispanics highlights and levels of amyloid genetics in ischemic stroke: candidate loci for precursor protein the MRI-GENIE study brain white matter hyperintensities Table of Contents Neurology.org/ng Online ISSN: 2376-7839 Volume 3, Number 5, October 2017 EDITORIAL e195 No rare deleterious variants from STK32B, e196 Genomic links between blast exposure, brain injury, PPARGC1A,andCTNNA3 are associated with and Alzheimer disease essential tremor Y.P. Conley and R. Diaz-Arrastia G. Houle, A. Ambalavanan, J.-F. Schmouth, Companion article, e186 C.S. Leblond, D. Spiegelman, S.B. Laurent, C.V. Bourassa, C. Grayson, M. Panisset, S. Chouinard, ARTICLES N. Dupré, C. Vilariño-Güell, A. Rajput, S.L. Girard, e186 Moderate blast exposure alters gene expression and P.A. Dion, and G.A. Rouleau levels of amyloid precursor protein J. Gill, A. Cashion, N. Osier, L. Arcurio, V. Motamedi, K.C. Dell, W. Carr, H.-S. Kim, S. Yun, P. Walker, e183 Ataxia-pancytopenia syndrome with SAMD9L S. Ahlers, M. LoPresti, and A. Yarnell mutations Editorial, e196 S. Gorcenco, J. Komulainen-Ebrahim, K. Nordborg, M. Suo-Palosaari, S. Andréasson, J. Krüger, e177 Whole-exome sequencing associates novel C. Nilsson, U. Kjellström, E. Rahikkala, CSMD1 gene mutations with familial Parkinson D. Turkiewicz, M. Karlberg, L. Nilsson, disease J. Cammenga, U. Tedgård, J. Davidsson, J. Ruiz-Martínez, L.J. Azcona, A. Bergareche, J.
    [Show full text]
  • A Resource for Exploring the Understudied Human Kinome for Research and Therapeutic
    bioRxiv preprint doi: https://doi.org/10.1101/2020.04.02.022277; this version posted March 11, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. A resource for exploring the understudied human kinome for research and therapeutic opportunities Nienke Moret1,2,*, Changchang Liu1,2,*, Benjamin M. Gyori2, John A. Bachman,2, Albert Steppi2, Clemens Hug2, Rahil Taujale3, Liang-Chin Huang3, Matthew E. Berginski1,4,5, Shawn M. Gomez1,4,5, Natarajan Kannan,1,3 and Peter K. Sorger1,2,† *These authors contributed equally † Corresponding author 1The NIH Understudied Kinome Consortium 2Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Program in Therapeutic Science, Harvard Medical School, Boston, Massachusetts 02115, USA 3 Institute of Bioinformatics, University of Georgia, Athens, GA, 30602 USA 4 Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA 5 Joint Department of Biomedical Engineering at the University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, NC 27599, USA † Peter Sorger Warren Alpert 432 200 Longwood Avenue Harvard Medical School, Boston MA 02115 [email protected] cc: [email protected] 617-432-6901 ORCID Numbers Peter K. Sorger 0000-0002-3364-1838 Nienke Moret 0000-0001-6038-6863 Changchang Liu 0000-0003-4594-4577 Benjamin M. Gyori 0000-0001-9439-5346 John A. Bachman 0000-0001-6095-2466 Albert Steppi 0000-0001-5871-6245 Shawn M.
    [Show full text]
  • Network Analysis and Human Single Cell Brain Transcriptomics Reveal Novel Aspects of Alpha-Synuclein (SNCA) Biology
    bioRxiv preprint doi: https://doi.org/10.1101/2020.06.05.137166; this version posted June 8, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Network Analysis and Human Single Cell Brain Transcriptomics Reveal Novel Aspects of Alpha-Synuclein (SNCA) Biology Erin Teeple1, Khushboo Jindal1, Beril Kiragasi2, Siddharth Annaldasula1, Ann Byrne1, Lilly Chai1, Mahdiar Sadeghi1, Can Kayatekin2, Srinivas Shankara1, Katherine W. Klinger1, S. Pablo Sardi2, Stephen L. Madden1*, and Dinesh Kumar1* 1Translational Sciences, Sanofi, Framingham, MA 01701, USA 2Neurological and Rare Diseases Therapeutic Area, Sanofi, Framingham, MA 01701, USA * To whom correspondence should be addressed. Tel: 1-508-270-2459; Email: [email protected] * Correspondence may also be addressed to [email protected] ABSTRACT Alpha-synuclein (SNCA) aggregates are pathological hallmarks of synucleinopathies, neurodegenerative disorders including Parkinson’s Disease (PD) and Lewy Body Dementia (LBD). Functional networks are not yet well-characterized for SNCA by CNS cell type. We investigated cell- specific differences in SNCA expression using Allen Brain Database single-nucleus RNA-seq data from human Middle Temporal Gyrus (MTG, 15,928 nuclei) and Anterior Cingulate Cortex (ACC, 7,258 nuclei). Weighted gene co-expression analysis (WGCNA) and hierarchical clustering identified a conserved SNCA co-expression module. Module genes were highly conserved (p < 10-10) and most highly expressed in excitatory neurons versus inhibitory neurons and other glial cells. SNCA co-expression module genes from ACC and MTG regions were then used to construct a protein-protein interaction (PPI) network, with SNCA empirically top hub.
    [Show full text]
  • Chip-Seq and Functional Analysis of the SOX2 Gene in Colorectal Cancers
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Xiamen University Institutional Repository OMICS A Journal of Integrative Biology Volume 14, Number 4, 2010 ª Mary Ann Liebert, Inc. DOI: 10.1089/omi.2010.0053 ChIP-seq and Functional Analysis of the SOX2 Gene in Colorectal Cancers Xuefeng Fang,1,2 Wei Yu,2 Lisha Li,2 Jiaofang Shao,2 Na Zhao,2 Qiyun Chen,2 Zhiyun Ye,3 Sheng-Cai Lin,3 Shu Zheng,1 and Biaoyang Lin2,4,5 Abstract SOX2 is an HMG box containing transcription factor that has been implicated in various types of cancer, but its role in colorectal cancers (CRC) has not been studied. Here we show that SOX2 is overexpressed in CRC tissues compared with normal adjacent tissues using immunohistochemical staining and RT-PCR. We also observed an increased SOX2 expression in nucleus of colorectal cancer tissues (46%, 14/30 cases vs. 7%, 2/30 adjacent tissues). Furthermore, knockdown of SOX2 in SW620 colorectal cancer cells decreased their growth rates in vitro cell line, and in vivo in xenograft models. ChIP-Seq analysis of SOX2 revealed a consensus sequence of wwTGywTT. An integrated expression profiling and ChIP-seq analysis show that SOX2 is involved in the BMP signaling pathway, steroid metabolic process, histone modifications, and many receptor-mediated signaling pathways such as IGF1R and ITPR2 (Inositol 1,4,5-triphosphate receptor, type 2). Introduction showed that OCT4 and SOX2 could be used to generate in- duced pluripotent stem cells from human cord blood. olorectal cancer is the second most common malig- SOX2 is also overexpressed in several cancers including Cnancy in cancer patients and cause of cancer-related gastric cancer, breast cancer, pancreatic cancer, pulmonary mortality (Wiesner et al., 2003).
    [Show full text]
  • Using Intrinsic and Extrinsic Methods to Engineer Improved Expression of Recombinant Proteins and Retroviral Vectors in Mammalian Cells
    USING INTRINSIC AND EXTRINSIC METHODS TO ENGINEER IMPROVED EXPRESSION OF RECOMBINANT PROTEINS AND RETROVIRAL VECTORS IN MAMMALIAN CELLS By Sarah Inwood A dissertation submitted to Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland July 2018 © 2018 Sarah Inwood All Rights Reserved Abstract Recombinant proteins, produced by introducing DNA into producer cells, are important in biotechnology, pharmaceuticals and academia. While prokaryotic cells are still most commonly used in these fields, mammalian cells are becoming more prevalent, especially for human proteins such antibodies, due to their inherent ability to correctly fold proteins, and retroviral vectors, due to their viral pseudotyping. This dissertation focuses on engineering improvement of recombinant protein expression and retroviral vector titer using both intrinsic methods such as cell engineering and extrinsic methods such as process development. To this end, multiple strategies such as non-coding RNA, stable transfections, CRISPR/Cas9 knockout, high-throughput screenings, and bioreactor perfusion processes were employed. Retroviral vectors have been of interest for some time due to their ability to modify genomes with relative ease and safety. This is increasingly so with the advancement of adoptive T-cell therapy, which is the transfer of T-Cells into a patient. These T-cells, often autologous, are typically modified, via various methods including retroviral vectors. Using mir-22-3p, which improves recombinant protein production, the first strategy was to identify gene targets of this microRNA that also improve recombinant protein expression. A microarray analysis was followed by bioinformatics; combining the results of the microarray with the predicted microRNA targets and the results of a high-throughput siRNA screen.
    [Show full text]
  • Osu1227282252.Pdf (1.38
    SELECTIVE ANDROGEN RECEPTOR MODULATOR (SARM) ACTION: ANDROGEN THERAPY REVISITED DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Christopher C Coss, B.S. *** The Ohio State University 2008 Dissertation Committee: Approved by Dr. James T. Dalton, Advisor Dr. Robert W. Brueggemeier _________________________________ Dr. Thomas D. Schmittgen Advisor Dr. Mamuka Kvaratskhelia Pharmacy Graduate Program ABSTRACT Despite continuing advances in the clinical development of selective androgen receptor modulators (SARMs) for male hypogonadism, osteoporosis, muscle wasting and myriad diseases of the prostate, mechanism remains controversial. To date, mechanistic work in the selective hormone receptor modulator (SRM) field has been dominated by selective estrogen receptor modulators (SERMs) where a full understanding of SERM action contributed to the development of second generation molecules with better selectivity and reduced side effects. It follows that a better understanding of SARM action could lead to improvements in rationale SARM design and even molecules tailor made for specific patient populations or disease states. The studies described herein were carried out to shed light on the molecular mechanism of aryl propionamide SARM action resulting in full efficacy in anabolic tissues (muscle and bone), while sparing androgenic tissues (prostate and skin). To this end genome wide androgen receptor (AR) promoter binding and transcriptional profiling in LNCaP prostate cancer cells was performed. In these experiments, the primary prostatic androgen 5α-dihydrostestosterone (DHT) was compared to aryl propionamide SARMs, revealing largely overlapping but distinct modes of action. These works support the existence of qualitative differences, not solely due to potency, underlying SARM mechanism.
    [Show full text]
  • Two New Arraytrack Libraries for Personalized Biomedical Research
    Xu et al. BMC Bioinformatics 2010, 11(Suppl 6):S6 http://www.biomedcentral.com/1471-2105/11/S6/S6 PROCEEDINGS Open Access Two new ArrayTrack libraries for personalized biomedical research Joshua Xu1*, Carolyn Wise2, Vijayalakshmi Varma2, Hong Fang1, Baitang Ning2, Huixiao Hong3, Weida Tong3, Jim Kaput2 From Seventh Annual MCBIOS Conference. Bioinformatics: Systems, Biology, Informatics and Computation Jonesboro, AR, USA. 19-20 February 2010 Abstract Background: Recent advances in high-throughput genotyping technology are paving the way for research in personalized medicine and nutrition. However, most of the genetic markers identified from association studies account for a small contribution to the total risk/benefit of the studied phenotypic trait. Testing whether the candidate genes identified by association studies are causal is critically important to the development of personalized medicine and nutrition. An efficient data mining strategy and a set of sophisticated tools are necessary to help better understand and utilize the findings from genetic association studies. Description: SNP (single nucleotide polymorphism) and QTL (quantitative trait locus) libraries were constructed and incorporated into ArrayTrack, with user-friendly interfaces and powerful search features. Data from several public repositories were collected in the SNP and QTL libraries and connected to other domain libraries (genes, proteins, metabolites, and pathways) in ArrayTrack. Linking the data sets within ArrayTrack allows searching of SNP and QTL data as well as their relationships to other biological molecules. The SNP library includes approximately 15 million human SNPs and their annotations, while the QTL library contains publically available QTLs identified in mouse, rat, and human. The QTL library was developed for finding the overlap between the map position of a candidate or metabolic gene and QTLs from these species.
    [Show full text]
  • Hidden Proteome of Synaptic Vesicles in the Mammalian Brain
    Hidden proteome of synaptic vesicles in the mammalian brain Zacharie Taoufiqa,1, Momchil Ninovb, Alejandro Villar-Brionesc, Han-Ying Wanga, Toshio Sasakid, Michael C. Royc, Francois Beauchaina, Yasunori Morie, Tomofumi Yoshidae, Shigeo Takamorie, Reinhard Jahnb,1, and Tomoyuki Takahashia,1 aCellular and Molecular Synaptic Function Unit, Okinawa Institute of Science and Technology Graduate University, Okinawa 904-0495, Japan; bDepartment of Neurobiology, Max Planck Institute for Biophysical Chemistry, D-37077 Göttingen, Germany; cInstrumental Analysis Section, Okinawa Institute of Science and Technology Graduate University, Okinawa 904-0495, Japan; dImaging Section, Okinawa Institute of Science and Technology Graduate University, Okinawa 904-0495, Japan; and eLaboratory of Neural Membrane Biology, Graduate School of Brain Science, Doshisha University, 610-0394 Kyoto, Japan Contributed by Reinhard Jahn, November 11, 2020 (sent for review June 15, 2020; reviewed by Yukiko Goda, Stefan Hallermann, and August B. Smit) Current proteomic studies clarified canonical synaptic proteins that proteomics, combined with subcellular fractionation, yields pro- are common to many types of synapses. However, proteins of tein inventories of high complexity. For instance, >2,000 protein diversified functions in a subset of synapses are largely hidden species were identified in synaptosomes (1), ∼400 in the SV fraction because of their low abundance or structural similarities to abun- (2), ∼1,500 in postsynaptic densities (3), and ∼100inanAZ- dant proteins. To overcome this limitation, we have developed an enriched preparation (4). “ultra-definition” (UD) subcellular proteomic workflow. Using pu- While these studies provide insights into the protein compo- rified synaptic vesicle (SV) fraction from rat brain, we identified sition of synaptic structures, they are still inherently limited for 1,466 proteins, three times more than reported previously.
    [Show full text]